Clobazam

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1394 publications

Characterizing SCN1A-Related Disorders Using Real-World Data Across 681 Patient-Years.

Characterizing SCN1A-Related Disorders Using Real-World Data Across 681 Patient-Years.

Journal: medRxiv : the preprint server for health sciences
Published: March 23, 2026

Effectiveness of adjunctive low-dose clobazam in adults with focal drug-resistant epilepsy and incomplete response to cenobamate: A real-world study.

Effectiveness of adjunctive low-dose clobazam in adults with focal drug-resistant epilepsy and incomplete response to cenobamate: A real-world study.

Journal: Epilepsia open
Published: January 28, 2026

Polysubstance overdose with cenobamate, levetiracetam and clobazam: Insights into cenobamate toxicity.

Polysubstance overdose with cenobamate, levetiracetam and clobazam: Insights into cenobamate toxicity.

Journal: Seizure
Published: January 27, 2026

Efficacy of Dravet Syndrome Treatments in a Subset of Individuals with 2q24.3 Deletion: A-5 Patient Case Series.

Efficacy of Dravet Syndrome Treatments in a Subset of Individuals with 2q24.3 Deletion: A-5 Patient Case Series.

Journal: Journal of child neurology
Published: January 21, 2026

Seizure Clusters: Current Concepts in Definition and Treatment.

Seizure Clusters: Current Concepts in Definition and Treatment.

Journal: Journal of clinical medicine
Published: January 15, 2026

Clobazam in Adult Drug-Resistant Epilepsy: Excellent Long-Term Retention and Potential Synergy with Neuromodulation.

Clobazam in Adult Drug-Resistant Epilepsy: Excellent Long-Term Retention and Potential Synergy with Neuromodulation.

Journal: Cureus
Published: January 08, 2026

Management of febrile seizures in Türkiye: A nationwide survey of pediatricians and pediatric neurologists.

Management of febrile seizures in Türkiye: A nationwide survey of pediatricians and pediatric neurologists.

Journal: Brain & development
Published: December 30, 2025

Pharmacokinetic variability and complex two-way interactions with cenobamate in patients with refractory epilepsy.

Pharmacokinetic variability and complex two-way interactions with cenobamate in patients with refractory epilepsy.

Journal: Epilepsia
Published: December 19, 2025

Prognostic Value of Interim PSMA-PET Total Tumor Volume for Overall Survival Within ENZA-p, A Randomized Phase 2 Trial of Enzalutamide Versus Enzalutamide Plus [177Lu] Lu-PSMA-617 (ANZUP1901).

Prognostic Value of Interim PSMA-PET Total Tumor Volume for Overall Survival Within ENZA-p, A Randomized Phase 2 Trial of Enzalutamide Versus Enzalutamide Plus [177Lu] Lu-PSMA-617 (ANZUP1901).

Journal: European urology
Published: December 14, 2025

Therapeutic Drug Monitoring of Clobazam, Perampanel, and Lacosamide Using a UPLC-MS/MS Method: Analysis of 5-Year Experience in a Large Cohort of Pediatric Epilepsy Patients From China.

Therapeutic Drug Monitoring of Clobazam, Perampanel, and Lacosamide Using a UPLC-MS/MS Method: Analysis of 5-Year Experience in a Large Cohort of Pediatric Epilepsy Patients From China.

Journal: Biomedical chromatography : BMC
Published: December 08, 2025

Adjunctive Use of Cenobamate in Paediatric Drug-Resistant Epilepsy: A Real-World, Single-Centre Experience.

Adjunctive Use of Cenobamate in Paediatric Drug-Resistant Epilepsy: A Real-World, Single-Centre Experience.

Journal: Journal of clinical medicine
Published: December 05, 2025

Drug-induced cataract: a real-world study based on the food and drug administration adverse event reporting system database.

Drug-induced cataract: a real-world study based on the food and drug administration adverse event reporting system database.

Journal: Frontiers in medicine
Published: December 02, 2025
Showing 1-12 of 1,394

Last Updated: 04/28/2026